This week we discuss the long awaited PEXIVAS trial. Reduced dose steroids win, and PLEX loses. Or does it?
AMBER Trial: The Visual Abstract
Excellent visual abstract for this week’s NephJC on patiromer and spironolactone by Verner Venegas
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.
Excellent visual abstract for this week’s NephJC on patiromer and spironolactone by Verner Venegas